In other words, we demonstrated that although CENPF-CHK1 transcriptional regulation existed in breast cancer, ADR suppressed it in ER+/PR+/HER2- cancer cells and enhanced it in ER-/PR-/HER2- cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.